The secreted glycoprotein CREG inhibits cell growth dependent on the mannose-6-phosphate/insulin-like growth factor II receptor
- 21 August 2003
- journal article
- Published by Springer Nature in Oncogene
- Vol. 22 (35) , 5436-5445
- https://doi.org/10.1038/sj.onc.1206670
Abstract
Secreted proteins and their cognate receptors are implicated in a myriad of activities that regulate cell proliferation, differentiation, and development. CREG, a cellular repressor of E1A-stimulated genes, is a secreted glycoprotein that antagonizes cellular transformation by E1A and ras. We have previously shown that CREG expression is induced very early during differentiation of pluripotent cells and, even in the absence of other inducers, CREG promotes neuronal differentiation of human teratocarcinoma NTERA-2 cells. Here we show that ectopic expression of CREG in NTERA-2 cells results in a delay of the G1/S phase transition of the cell cycle and growth inhibition. We show that CREG binds directly to the mannose-6-phosphate/insulin-like growth factor II receptor (M6P/IGF2R) dependent on CREG glycosylation. The M6P/IGF2R is a tumor suppressor that functions to control cell growth through interactions with multiple ligands. By analysing CREG activity in cells lacking M6P/IGF2R expression, we show that this receptor is required for CREG-induced growth inhibition. These studies reveal that CREG inhibits cell growth dependent on the M6P/IGF2R and suggest that interactions between CREG and a well-characterized tumor suppressor may contribute to regulation of proliferation and differentiation in multiple lineages.Keywords
This publication has 46 references indexed in Scilit:
- Identification and Characterization of Novel Members of the CREG Family, Putative Secreted Glycoproteins Expressed Specifically in BrainGenomics, 2002
- Towards a human repertoire of monocytic lysosomal proteinsElectrophoresis, 2000
- The secreted glycoprotein CREG enhances differentiation of NTERA-2 human embryonal carcinoma cellsOncogene, 2000
- M6P/IGF2R is mutated in squamous cell carcinoma of the lungOncogene, 2000
- Microsatellite instability in the insulin–like growth factor II receptor gene in gastrointestinal tumoursNature Genetics, 1996
- M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosityNature Genetics, 1995
- All-trans-retinoic acid and hexamethylene bisacetamide (HMBA) regulate TGF-α and Hst-1/kFGF expression in differentiation sensitive but not in resistant human teratocarcinomasDifferentiation, 1994
- β‐Galactosidase decreases the binding affinity of the insulin‐like‐growth‐factor‐II/mannose‐6‐phosphate receptor for insulin‐like‐growth‐factor IIEuropean Journal of Biochemistry, 1990
- Mannose 6-phosphate/insulin like growth factor II receptor: The two types of ligands bind simultaneously to one receptor at different sitesBiochemical and Biophysical Research Communications, 1988
- Glycolipid core structure switching from globo- to lacto- and ganglio-series during retinoic acid-induced differentiation of TERA-2-derived human embryonal carcinoma cellsDevelopmental Biology, 1987